#483 of the S&P 500: Quest Diagnostics, Inc. (NYSE:DGX)
Quest Diagnostics is a provider of diagnostic information services, including routine testing, esoteric or gene-based testing and anatomic pathology testing and also a provider of risk assessment services for the life insurance industry. Co. provides access in the U.S. to diagnostic information services through its network of laboratories and Co.-owned patient service centers. Co. is also a provider of testing for clinical trials and testing for drugs-of-abuse. Co.'s diagnostics products business manufactures and markets diagnostic test kits. At Dec 31 2012, Co.'s operations are organized in two business groups: Diagnostic Information Services; and Diagnostic Solutions. Open the DGX Page at ETF Channel »
Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Service. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20
minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.